Corporate ActionJul 30, 2026, 12:20 AM
Quantum BioPharma Settles CAD$123,487 Debt by Issuing 30,948 Shares
AI Summary
Quantum BioPharma Ltd. announced the closing of a debt settlement totaling CAD$123,487.43. The settlement was made through the issuance of 30,948 Class B subordinate voting shares to creditors and insiders at a deemed price of CAD$3.99 per share. The company, focused on neurodegenerative, metabolic, and alcohol misuse disorders, noted that these shares are not registered under the U.S. Securities Act.
Key Highlights
- Quantum BioPharma settled CAD$123,487.43 in debt.
- The debt was owed to arm's length creditors and insiders.
- The company issued 30,948 Class B subordinate voting shares.
- Shares were issued at a deemed price of CAD$3.99 per share.
- The securities are not registered under the U.S. Securities Act.
Price Impact
More from QNTM